WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2011140236) TRIAMCINOLONE ACETONIDE FORMULATIONS FOR TREATING DERMATITIS AND PSORIASIS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2011/140236    International Application No.:    PCT/US2011/035216
Publication Date: 10.11.2011 International Filing Date: 04.05.2011
IPC:
A61K 9/06 (2006.01), A61K 47/30 (2006.01), A61K 47/34 (2006.01), A61K 31/56 (2006.01), A61K 31/57 (2006.01), A61P 17/00 (2006.01)
Applicants: NUVO RESEARCH INC. [CA/CA]; 7560 Airport Road, Unit 10 Mississauga, Ontario L4T 4H4 (CA) (For All Designated States Except US).
ALIYAR, Hyder [US/US]; (US) (For US Only).
ZHANG, Jie [US/US]; (US) (For US Only)
Inventors: ALIYAR, Hyder; (US).
ZHANG, Jie; (US)
Agent: OAKESON, Gary, P.; Thorpe North & Western LLP 8180 S. 700 E., Suite 350 Sandy, Utah 84070 (US)
Priority Data:
61/332,157 06.05.2010 US
Title (EN) TRIAMCINOLONE ACETONIDE FORMULATIONS FOR TREATING DERMATITIS AND PSORIASIS
(FR) FORMULATIONS D'ACÉTONIDE DE TRIAMCINOLONE POUR LE TRAITEMENT DE DERMATITE ET DU PSORIASIS
Abstract: front page image
(EN)The present invention is drawn to formulations and related methods for treating dermatitis or psoriasis. The formulation can include triamcinolone acetonide, a polymer selected from the group of a poly(2-hydroxyalkylacrylate), a poly(2-hydroxyalkylmethacrylate), and combinations thereof. The formulation also includes a volatile solvent system including at least one volatile solvent, and a non-volatile solvent system including at least one non-volatile solvent.
(FR)La présente invention concerne des formulations et des méthodes connexes de traitement de dermatite ou du psoriasis. La formulation peut comprendre de l'acétonide de triamcinolone, un polymère sélectionné dans le groupe d'un poly(2-hydroxyalkylacrylate), d'un poly(2-hydroxyalkylméthacrylate), et des combinaisons de ceux-ci. La formulation comprend également un système de solvant volatil composé au moins d'un solvant volatil et un système de solvant non volatil composé au moins d'un solvant non volatil.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)